PMS42 COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
Abstract
Authors
O Purcaru PC Taylor P Emery S Palmer
O Purcaru PC Taylor P Emery S Palmer
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now